Skip to main navigation Skip to search Skip to main content

A unified platform for the rapid assembly of glutarimides for Cereblon E3 ligase modulatory drugs

  • David M. Whalley
  • , Olivier Lorthioir
  • , Niall A. Anderson
  • , Erin Braybrooke
  • , Susannah C. Coote
  • , Sylvain Demanze
  • , Holly L. Douglas
  • , Okky Dwichandra Putra
  • , Katie Proctor
  • , Yuanyuan Si
  • , Sam Staniland
  • , Stephen Stokes
  • , Alfie Woodhouse
  • AstraZeneca UK Ltd
  • AstraZeneca Gothenburg

Research output: Contribution to journalArticlepeer-review

Abstract

Glutarimide-containing Cereblon (CRBN) ligands are critical motifs for PROTACs, molecular glue degraders and next-generation Cereblon E3 ligase modulatory drugs (CELMoDs), which represent promising therapeutic modalities in targeted protein degradation. However, the multistep synthetic routes required to access glutarimide scaffolds continue to present formidable challenges for medicinal chemists, limiting rapid structure–activity relationship (SAR) exploration and late-stage diversification. To streamline access to these privileged motifs, modular and efficient methodologies are still highly desirable. Here, we report a unified organocatalytic synthesis platform for the rapid assembly of diverse glutarimide derivatives from readily available nitrogen heterocycles. Employing a sequence of phosphine-catalysed C–N bond formation, metal-free Giese addition and acid-mediated cyclisation, this approach provides high selectivity, broad functional group tolerance and operational simplicity under conditions amenable to both multigram synthesis and high-throughput parallel synthesis. Using this platform, we rapidly prepare CRBN binder libraries, access control analogues (for example, N‑alkylated glutarimides) and perform late‑stage functionalisation of bioactive molecules. This strategy could offer a transformative solution for the efficient and cost-effective synthesis of CRBN-targeted therapeutics and chemical biology probes, overcoming longstanding synthetic bottlenecks in the field.

Original languageEnglish
Article number7812
Number of pages12
JournalNature Communications
Volume17
Issue number1
Early online date21 Jun 2026
DOIs
Publication statusPublished - 21 Jun 2026

Data Availability Statement

The authors declare that the data supporting the findings of this study are available within the paper and its Supplementary Information files. Should any raw data files be needed in another format they are available from the corresponding author upon request. Crystallographic data for compound 55 has been deposited at the Cambridge Crystallographic Data Centre, under deposition number CCDC 2519893.

Acknowledgements

The authors would like to thank Jamie Scott, David Andrews, Iacavos Michaelides and Meizhong Jin for valuable discussions. We would also like to thank David Longmire for additional assistance with NMR analysis, Ryan Greenwood for assistance with the Lucent360TM photoreactor and Toby Athersuch for assistance with the physicochemical assay data.

ASJC Scopus subject areas

  • General Chemistry
  • General Biochemistry,Genetics and Molecular Biology
  • General
  • General Physics and Astronomy

Fingerprint

Dive into the research topics of 'A unified platform for the rapid assembly of glutarimides for Cereblon E3 ligase modulatory drugs'. Together they form a unique fingerprint.

Cite this